Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Jul 2022 for Jazz Pharmaceuticals plc, €79. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher J. Tovey: trading record in brief
Christopher J. Tovey (chief executive) discloses dealings in 2 companies, chiefly Jazz Pharmaceuticals plc and GW Pharmaceuticals PLC. The record holds 5 filings, for trades running from 5 May 2021 to 5 July 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 7 July 2022, reports an option exercise of €79 in Jazz Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher J. Tovey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,032 shares@ US$0.020.0% of flowOrdinary SharesSEC:0001765581-22-000069:0
1,096 shares@ US$153.220.0011% mcap100.0% of flowOrdinary SharesSEC:0001765581-22-000043:0
7,820 shares0Ordinary SharesSEC:0001765581-22-000032:0
2,496 sharesOrdinary SharesSEC:0000899243-21-018673:0
9,091 shares0Ordinary SharesSEC:0001765581-21-000057:0
5 of 5 declarations
